A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017
Clinical trial NCT03626467 · COMPLETED
Trial details
- NCT number
- NCT03626467
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2021-07-14
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.